当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
GRASTEK, Timothy Grass Pollen Allergen Extract
药品名称
GRASTEK, Timothy Grass Pollen Allergen Extract
承诺描述
Conduct a post-market claims-based study to further describe the safety profile of GRASTEK in marketed use in the United States. The study will enroll all new users of GRASTEK identified through claims data from a large US health insurance database for a period of at least three years from launch of GRASTEK. The study observation period will last for at least 3 years and until at least 10,000 patients are accrued between both post-market studies. Outcomes of interest identified through claims data will be verified using medical record review.
承诺状态描述
Delayed. The study completion date has passed, and the study is not yet complete.